Just over a year ago, 23andMe’s co-founder and CEO Anne Wojcicki was assuring the life sciences industry that the company was a “full-fledged biotech” committed to drug R&D.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,